Tuesday, November 24, 2020
Home Business EU could pay over $10b for vaccines

EU could pay over $10b for vaccines

DM Monitoring

BRUSSELS: The European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfizer-BioNTech and CureVac, an EU official involved in the talks told media.
The bloc has agreed to pay 15.50 euros ($18.34) per dose for the COVID-19 vaccine candidate being developed by Pfizer and BioNTech, according to the official. That would mean an overall price of up to 3.1 billion euros ($3.7 billion) for 200 million doses, rising to 4.65 billion euros if another optional 100 million doses are purchased under the deal, the official said. The pricing information, previously undisclosed, confirms the EU is paying less per dose than the United States for an initial supply of that vaccine, as reported by Reuters last week.
The deal includes an insurance for EU countries to get compensation if the companies divert doses to the United States, according to the source, who requested anonymity due to the sensitivity of the matter.
The EU has separately agreed to pay 10 euros ($11.84) per dose for an initial supply of 225 million doses of the vaccine candidate from CureVac, a discount from the 12 euros the company set as the price for the shot, the official said.
The bloc struck the deal with CureVac this week to secure the supply of up to 405 million doses, of which 180 million are optional.
The official said CureVac had committed to starting deliveries by the end of March. It is unclear whether the additional 180 million doses would cost 10 or 12 euros each. Under the 10-euro price, though, the bloc would pay 4.05 billion euros for 405 million doses.
A spokesman for the European Commission, the bloc’s executive body, declined to comment on terms and pricing of vaccine contracts because they are confidential. Germany’s BioNTech and CureVac declined to comment. U.S. drugmaker Pfizer said it and BioNTech were using a tiered pricing formula based on volume and delivery dates and that the EU deal represented the largest initial order of its vaccine candidate to date. “We are not disclosing further details of this agreement,” it added.
Pfizer and BioNTech said on Wednesday that final data showed their shot was 95% effective against COVID-19, and that they could start distributing shots before Christmas should they secure emergency authorisations..
In July the U.S. government agreed with Pfizer to pay $19.5 per dose for 100 million, with an option to buy a further 500 million under terms to be negotiated separately.
The lower price partly reflects the financial support given by the European Union to BioNTech for the drug’s development, a second EU official told Reuters last week. Both the Pfizer-BioNTech and CureVac candidates are based on new messenger RNA (mRNA) technology and designed to be administered in two doses. That means, for the EU’s Pfizer shot, it would cost 31 euros to inoculate one person.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Will react to US Admiral’s Taiwan visit, says China

BEIJING: Chinese Foreign Ministry spokesperson Zhao Lijian on Monday said China firmly opposed any official or military interactions between the United States and Taiwan...

Govt moves to curb COVID-19

-Education Minister announces closure of educational institutions from 26th By Ajmal Khan Yousafzai ISLAMABAD: The federal government on Monday announced the closure of all educational institutions...

Netanyahu meets MBS, Pompeo: Israeli Minister

-Saudi Foreign Minister denies the meeting DM Monitoring RIYADH: Prime Minister Benjamin Netanyahu met the Saudi crown prince in Saudi Arabia, an Israeli cabinet minister said...

PM convenes NCC meeting today

From Zeeshan Mirza KARACHI: Amid a surge in Covid-19 cases, Prime Minister Imran Khan on Monday convened a meeting of the National Coordination Committee (NCC)...

Recent Comments